Contributed by Terence Hwa; received December 27, 2024; accepted March 21, 2025; reviewed by Vickery L. Arcus and Seppe Kuehn ...
Abstract: The majority of approaches to affective computing that deal with Valence, Arousal and Dominance (VAD) ratings neglect their interdependencies. Although initially postulated as independent ...
ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) are equally recommended as first-line treatment for cardiovascular and renal protection in clinical practice.
After becoming the first group to therapeutically edit human RNA in October 2024, Wave Life Sciences has released more data from its ongoing alpha-1 antitrypsin deficiency (AATD) clinical trial—and ...
Mayo Clinic researchers have pinpointed how excessive alcohol consumption contributes to fatty liver disease, a condition that affects more than one in three people in the U.S. Also known as Metabolic ...
Roche Pharma Research and Early Development, Neuroscience and Rare Disease Discovery and Translational Area, Roche Innovation Center Basel, 4070 Basel, Switzerland Roche Pharma Research and Early ...
Department of Chemistry, University of California, Davis, California 95616, United States ...
Researchers at the University of California San Diego School of Medicine have identified a new investigational drug that shows promise in treating metabolic dysfunction-associated steatohepatitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback